Autonomize AI: $28M Funding for Healthcare AI Agents
- Autonomize AI, a company specializing in AI-driven healthcare solutions, has secured $28 million in Series A funding.
- The funding round was led by Valtruis and The Cigna Group Ventures, along with participation from tau Ventures and other strategic investors.
- Founded in 2022 by Ganesh Padmanabhan and Kris Nair, Autonomize AI is focused on improving healthcare delivery through its Agentic AI Orchestration platform.
Autonomize AI, a leader in AI-driven healthcare, just secured $28 million in Series A funding, signaling a major leap forward for its Agentic AI Orchestration platform. This investment, led by Valtruis and The Cigna Group Ventures, will fuel the expansion of their solutions. The platform is designed to revolutionize healthcare by greatly reducing administrative complexities with intelligent assistants.The platform presently deployed with Fortune 100 healthcare enterprises already saves an estimated 36,000 clinical hours monthly while generating over 100,000 automated care plans, and speeding up prior authorization/claim processes by up to 50%. Founded in 2022 by Ganesh Padmanabhan and Kris Nair, Autonomize AI aims to make healthcare more accessible and efficient, and you can read about it on News Directory 3. Discover what’s next for the promising new AI healthcare agent.
Autonomize AI Secures $28M Series A Funding for Healthcare AI
Autonomize AI, a company specializing in AI-driven healthcare solutions, has secured $28 million in Series A funding. This latest investment brings their total capital raised to $32 million.
The funding round was led by Valtruis and The Cigna Group Ventures, along with participation from tau Ventures and other strategic investors. Existing investors, including Asset Management Ventures, ATX Venture Partners, and Capital Factory, also contributed.
Founded in 2022 by Ganesh Padmanabhan and Kris Nair, Autonomize AI is focused on improving healthcare delivery through its Agentic AI Orchestration platform. The new funding will enable the company to expand its solutions, helping healthcare organizations streamline administrative processes, increase clinician efficiency, and improve patient care.
Autonomize AI’s platform uses pre-trained AI agents that function as intelligent assistants across various workflows,including care management,utilization review,and benefits coordination. These agents work together within a multi-agent system designed to align with real-world healthcare operations.
The platform is currently deployed within Fortune 100 healthcare enterprises and has demonstrated significant operational improvements.
- It saves 36,000 clinical hours per month by automating administrative tasks.
- It generates over 100,000 automated care plans monthly.
- It accelerates decisions on prior authorizations and claims by up to 50%.
Autonomize AI emphasizes enterprise-grade explainability, openness, and compliance within its platform. It supports regulated healthcare environments with human-in-the-loop systems.
“The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unneeded friction,” said Ganesh Padmanabhan, CEO of Autonomize AI. “Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is.”
What’s next
With this new funding, Autonomize AI aims to further expand its reach across healthcare and life sciences, addressing operational challenges and making healthcare more accessible and efficient.